Aviva (OTCMKTS:AVVIY) Receives New Coverage from Analysts at JPMorgan Chase & Co.

Equities researchers at JPMorgan Chase & Co. initiated coverage on shares of Aviva (OTCMKTS:AVVIY – Get Free Report) in a research note issued on Friday, FlyOnTheWall reports. The brokerage set an “overweight” rating on the financial services provider’s stock.

Several other analysts also recently issued reports on the company. HSBC upgraded Aviva from a “hold” rating to a “buy” rating in a research note on Friday, June 30th. Berenberg Bank boosted their price target on Aviva from GBX 481 ($5.96) to GBX 493 ($6.11) in a report on Monday, August 21st. Morgan Stanley upped their target price on Aviva from GBX 470 ($5.82) to GBX 480 ($5.95) in a report on Friday, August 18th. Barclays increased their price target on Aviva from GBX 470 ($5.82) to GBX 472 ($5.85) in a research note on Thursday, September 7th. Finally, Keefe, Bruyette & Woods cut Aviva from an “outperform” rating to a “market perform” rating in a research note on Friday, July 28th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $488.00.

Get Aviva alerts:

Read Our Latest Report on AVVIY

Aviva Price Performance

AVVIY stock opened at $9.93 on Friday. The business’s 50 day simple moving average is $9.84 and its 200 day simple moving average is $10.10. Aviva has a 1-year low of $8.05 and a 1-year high of $11.35. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.49 and a quick ratio of 1.74.

About Aviva

(Get Free Report)

Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products.

Recommended Stories

• Five stocks we like better than Aviva
• How to Invest in Grocery Stores
• 3 Reasons This Sleeping Giant Is About To Wake Up
• Health Care Stocks Explained: Why You Might Want to Invest
• MarketBeat Week in Review – 9/18 – 9/22
• How to Capture the Benefits of Dividend Increases
• 52-week Low Names To Tip The Upside Scale In Your Favor

Receive News & Ratings for Aviva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aviva and related companies with MarketBeat.com's FREE daily email newsletter.